The global genomics market size is expected to reach USD 62.9 billion by 2028, according to a new report by Contrive Datum Insights, Inc. It is expected to expand at a CAGR of 15.35% from 2021 to 2028. A rise in the demand for the solutions to catalog vast genomic information into a usable form and to utilize it in clinical workflows is expected to drive the market. This has also led to an increase in the market competition, coupled with the development of breakthrough genomic technologies by Veritas Genetics, 23andMe, and other key players. In August 2020, Ancestry launched a new next-generation sequencing-based tool to screen genes linked to blood disorders, colon cancer, heart diseases, and breast cancer. This product, developed by Quest Diagnostics, has a better DNA analysis efficiency when compared to microarray-based testing.

Key suggestions from the report:

  • In the products segment, the consumables and reagents segment is expected to register the fastest CAGR over the forecast period owing to the high volume requirement for reagents and consumables for genomic analysis
  • In the services segment, NGS-based services dominated the market in 2020. The use of NGS-based services for the analysis of the SARS-CoV-2 genome drives the segment. The COVID-19 Genomics UK (COG-UK) Consortium delivers rapid and large-scale whole-genome sequencing of SARS-CoV-2
  • By application and technology, functional genomics led the market in 2020 due to the development of high-throughput technologies for the gene as well as protein studies. The generation of a large amount of sequencing data has led to significant developments in the segment
  • Based on end use, pharmaceutical and biotechnology companies dominated the market in 2020. Pharmaceutical and biotechnology companies like Menlo Park; Grail, Inc.; and Regeneron Pharmaceutical, Inc. have initiated large-scale genomic sequencing projects in collaboration with both community health systems and academic medical centers
  • Asia Pacific is expected to register the fastest growth rate from 2021 to 2028 owing to an increase in adoption and awareness about a number of genomics technologies in emerging countries, such as China and India, for the detection, treatment, and prognosis of various genetic disorders, such as diabetes and cancer

Read 224 page research report with ToC on “Genomics Market Size, Share & Trends Analysis Report By Application & Technology (Functional Genomics, Pathway Analysis), By Deliverable (Products, Services), By End-use, By Region, And Segment Forecasts, 2021 – 2028” at: https://bit.ly/2QgTRUe

Technological advancements in genetic technologies that include CGH, FISH, microarray, karyotyping, sequencing, and gene-editing tools have played a pivotal role in reshaping the healthcare systems and basic biomedical research. Furthermore, despite several ethical and legal issues, Direct-To-Consumer solutions are one of the most important innovations in the market for genomics as they help patients to perform genetic tests on their own.

The cost of reagents used in genomics has witnessed a continuous decline, which has led to an increase in adoption among small and mid-sized laboratories. However, with the introduction of novel technology and systems, the requirement for reagents is also changing.

The market has witnessed multiple product launches in 2020 owing to a rise in competition for the development of genomic testing solutions for COVID-19. For instance, in December 2020, ThermoFisher launched Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay—a new saliva-based PCR test for the detection of COVID-19 infection. Similarly, in June 2020, Cepheid announced the development of the Xpert Xpress SARS-CoV-2/Flu/RSV four-in-one test, which can detect these four pathogens from a single sample. This test can be run on Cepheid’s GeneXpert Systems.

Contrive Datum Insights has segmented the global genomics market on the basis of application and technology, deliverable, end-use, and region:

  • Genomics Application & Technology Outlook (Revenue, USD Million, 2017 – 2028)
  • Functional Genomics
  • Real-time PCR
  • Transfection
  • SNP Analysis
  • Mutational Analysis
  • Microarray Analysis
  • RNA Interference
  • Pathway Analysis
  • Microarray Analysis
  • Bead-based Analysis
  • Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
  • Real-time PCR
  • Biomarker Discovery
  • DNA Sequencing
  • Microarray Analysis
  • Real-time PCR
  • Mass Spectrometry
  • Statistical Analysis
  • Bioinformatics
  • Epigenetics
  • Bisulfite Sequencing
  • Microarray Analysis
  • Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
  • Methylated DNA Immunoprecipitation (MeDIP)
  • High Resolution Melt (HRM)
  • Chromatin Accessibility Assays
  • Others
  • Genomics Deliverable Outlook (Revenue, USD Million, 2017 – 2028)
  • Products
  • Instruments/Systems/Software
  • Consumables & Reagents
  • Services
  • NGS-based Services
  • Core Genomics Services
  • Biomarker Translation Services
  • Computational Services
  • Others
  • Genomics End-use Outlook (Revenue, USD Million, 2017 – 2028)
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Academic and Government Institutes
  • Clinical Research
  • Other End Users
  • Genomics Regional Outlook (Revenue, USD Million, 2017 – 2028)
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Genomics Market

  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies
  • Beijing Genomics Institute (BGI)
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Illumina, Inc.
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • QIAGEN N.V.
  • Quest diagnostics
  • Myriad Genetics, Inc.
  • Eppendorf AG
  • Eurofins Scientific
  • Color
  • 23andMe, Inc.

Get More Info:- https://bit.ly/2QgTRUe

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *